Navigation Links
Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/5/2008

SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 10th Annual BIO CEO and Investor Conference on Tuesday, February 12, 2008 at 2:45 p.m. EST (11:45 p.m. PST). The conference is being held at the Waldorf-Astoria Hotel in New York.

Steve Worland, Ph.D., President and Chief Executive Officer of Anadys Pharmaceuticals, Inc., will present an overview of Anadys and its two development-stage product candidates, ANA598 and ANA773.

The presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at http://www.anadyspharma.com. Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through February 26, 2008.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of chronic hepatitis C and ANA773, an oral TLR7 agonist prodrug for cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in the areas of hepatitis C and cancer. S
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCall...ncedthatNASDAQhasestablishedNovember27,2009astheex...ckholdersresultingfromthesecuritizationtransaction...ecember15,2009toallstockholdersofrecordontherecord...hareamountofthedividendat$1.67pershareofcommonstoc...
(Date:11/23/2009)... Contec’s Sporicidin dis...ctive hospital-grade disinfectants against H1N1 an...burg, SC (PRWEB) November 24, 2009 -- Contec Inc, ... has announced that their Sporicidin disinfectant...t all Influenza A viruses, including Pandemic 2009...
(Date:11/23/2009)..., MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--Frost&a...lthcarecompaniesfordemonstratingleadershipandinnov...thcareInnovationAwardsBanquetheldinSanAntonio,Texa...h/20081117/FSLOGO ) ,, TheHealthcareInnovationA...ntributiontothedeliveryandmanagementofhealthcare.S...
(Date:11/20/2009)... , , , , , , , ... , AUDIO: , A team of scientists ...rsity of Arizona, Cold Spring Harbor Laboratory an...e DNA of corn. The... , , Click h... , , , , , , , ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
... Trusted LASIK Surgeons launc...tory service and website at www.TrustedLASIKSurge...ers seeking to improve their vision and find a hig...hances of attaining 20-20 vision. What sets the T...screening process ensuring that only those who are...
...TTLE, March 25 Trubion Pharmaceuticals, Inc. (Nas...on partner Wyeth Pharmaceuticals, a division of Wy...al trial of SBI-087, Trubion,s next generation CD2...pus erythematosus (SLE). Based on Trubion,s Small ..., SBI-087 is also being evaluated in a Phase 1 cli...
... DIEGO, March 25 David Koos, Chairman and CEO of ...OTC Bulletin Board: BMSN), told the editors of The... news weekly, that there is an excellent possibili..." in ,09 because of new business alliances and con... banking, stem cell research, or cell culturing." ...
Other Biology Technology:Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 2Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 3Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 4Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 5Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 6Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 7Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 8Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE) 2Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE) 3Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview 2
(Date:11/23/2009)...C. The community-associated strain of the deadly ...nt to most common antibioticsposes a far greater h...ts way into hospitals, according to a study in the... , The new threat is easily picked up in fitnes...s increased the overall burden of MRSA within hosp...
(Date:11/23/2009)...ember 23, 2009 - The time of day matters to forest...per produced by a research team led by Professor M...,s vice-principal for research and colleagues in t...t. George campus. , Capitalizing on their prev... the research team examined how poplar trees use t...
(Date:11/23/2009)... -- More than 160 participants gathered this week ...URES INITIATIVE conference. This year,s topic, "Sy...ineers, and medical researchers to explore the eng...g the emerging field of synthetic biology. , Bon...Princeton University and this year,s conference ch...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 1Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 2U S Army Increases Medical and Dental School Benefits 49582 1U S Army Increases Medical and Dental School Benefits 49582 2U S Army Increases Medical and Dental School Benefits 49582 3
...cal systems across the earth are being affected by... analysis of information not previously assembled ...ude earlier leafing of trees and plants over many ...and altitudes in the northern hemisphere; changes ...stralia; and shifting of the oceans plankton and f...
...veloped what they believe is the first new mechani...et used to treat all HIV patients, which could eve...archers at the University of Michigan used compute...hen confirmed in the lab that the compound does in... target for AIDS treatment. The protease is necess...
...nce widespread in the Pacific Northwests western l...pression, conifer and invasive plant encroachment,...as much as 99 percent of the oak communities histo...new technical report titled "Evaluation of Landsca...rie, Washington" outlines the findings of a study ...
Other Biology News:Warming climate is changing life on global scale, says new study 2Compound has potential for new class of AIDS drugs 2
Goat Anti-Human EML1 (K-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Aldolase A (N-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
BPAEC (B302-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Human RECK (F-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: